Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches (2018)
- Authors:
- Autor USP: ULRICH, ALEXANDER HENNING - IQ
- Unidade: IQ
- DOI: 10.1016/j.pnpbp.2017.04.033
- Subjects: TRANSTORNO BIPOLAR; DOENÇA DE ALZHEIMER; CÉLULAS-TRONCO; LÍTIO
- Language: Inglês
- Imprenta:
- Source:
- Título: Progress in Neuropsychopharmacology & Biological Psychiatry
- ISSN: 0278-5846
- Volume/Número/Paginação/Ano: v. 80, p. 34-53, 2018
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
VELLOSO, juliana da Cruz Corrêa et al. Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches. Progress in Neuropsychopharmacology & Biological Psychiatry, v. 80, p. 34-53, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.pnpbp.2017.04.033. Acesso em: 18 jan. 2026. -
APA
Velloso, juliana da C. C., Gonçalves, M. C. B., Naaldijk, Y., Giacomelli, Á. O., Pillat, M. M., & Ulrich, H. (2018). Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches. Progress in Neuropsychopharmacology & Biological Psychiatry, 80, 34-53. doi:10.1016/j.pnpbp.2017.04.033 -
NLM
Velloso juliana da CC, Gonçalves MCB, Naaldijk Y, Giacomelli ÁO, Pillat MM, Ulrich H. Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches [Internet]. Progress in Neuropsychopharmacology & Biological Psychiatry. 2018 ; 80 34-53.[citado 2026 jan. 18 ] Available from: https://doi.org/10.1016/j.pnpbp.2017.04.033 -
Vancouver
Velloso juliana da CC, Gonçalves MCB, Naaldijk Y, Giacomelli ÁO, Pillat MM, Ulrich H. Pathophysiology in the comorbidity of Bipolar Disorder and Alzheimer's Disease: pharmacological and stem cell approaches [Internet]. Progress in Neuropsychopharmacology & Biological Psychiatry. 2018 ; 80 34-53.[citado 2026 jan. 18 ] Available from: https://doi.org/10.1016/j.pnpbp.2017.04.033 - Aluminum-induced alterations of purinergic signalling in embryonic neural progenitor cells
- Anti-inflamatory effect of the P2X7 receptor antagonist, Brilliant Blue G, in an animal model of Parkinson's disease
- Optimization of SELEX: comparison of different methods for monitoring the progress of in vitro selection of aptamers
- Reverted effect of mesenchymal stem cells in glioblastoma treated with agathisflavone and its selective antitumoral effect on cell viability, migration, and differentiation via STAT3
- Immobilized P2'X IND. 2' purinergic receptor stationary phase for chromatographic determination of pharmaceological properties and drug screening
- Kinins and microglial responses in bipolar disorder: a neuroinflammation hypothesis
- Pharmacological properties of suramin as non-competitive antagonist of rat P2X2 receptor
- Characterization of RNA aptamers as specific inhibitors of P2X4 receptors
- 'P2X IND. 2' and 'P2Y IND. 2' purinergic receptor specific RNA interference to study their participation in neuronal differentiation
- Kinin-B2 receptor mediated neuroprotection after NMDA excitotoxicity is reversed in the presence of Kinin-B1 receptor agonists
Informações sobre o DOI: 10.1016/j.pnpbp.2017.04.033 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
